P. Ciruela

P. Ciruela, N. Torner, Á. Domínguez, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

SARS-CoV-2 Catalonia contact tracing program: evaluation of key performance indicators

P. Ciruela, M. Jané Checa, M. Jané, 2022, BMC Public Health.

Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Epidemic and Nonepidemic Influenza Periods

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2019, Journal of Clinical Microbiology.

Invasive pneumococcal disease rates linked to meteorological factors and respiratory virus circulation (Catalonia, 2006–2012)

C. Muñoz-Almagro, P. Ciruela, R. Pallarés, 2016, BMC Public Health.

Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine.

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2021, Anales de pediatria.

Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study.

D. Fedson, P. Ciruela, A. Fenoll, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Indirect effects of Paediatric Conjugate Vaccines on Invasive Pneumococcal Disease in Older Adults.

Montse Morta, M. Curriu, M. Benítez, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2017, PloS one.

Are risk factors associated with invasive pneumococcal disease according to different serotypes?

C. Muñoz-Almagro, I. Jordan, L. Selva, 2013, Human vaccines & immunotherapeutics.

[Surveillance of the pandemic influenza (H1N1) 2009 in Catalonia: results and implications].

A. Plasència, T. Pumarola, J. Caylà, 2011, Revista espanola de salud publica.

The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital-based study.

P. Ciruela, A. Martínez, N. Torner, 2002, Vaccine.

Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.

C. Muñoz-Almagro, I. Jordan, L. Selva, 2011, Vaccine.

Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe

A. van der Ende, M. Knol, S. Ladhani, 2022, Emerging infectious diseases.

Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study

A. Serrano-Blanco, C. Muñoz-Almagro, P. Ciruela, 2020, Vaccines.

Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain

Montse Morta, M. Lanaspa, C. Muñoz-Almagro, 2020, PloS one.

Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project

S. Zeger, P. De Wals, L. Hammitt, 2021, Microorganisms.

Risk factors for invasive pneumococcal disease in a community with a high proportion of non vaccine serotypes.

C. Muñoz-Almagro, L. Selva, P. Ciruela, 2013, Vaccine.

The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage.

C. Muñoz-Almagro, P. Ciruela, R. Pallarés, 2018, Vaccine.

Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2–59 Months of Age, Spain

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2020, Emerging infectious diseases.

Vaccine Failures in Patients Properly Vaccinated with 13-Valent Pneumococcal Conjugate Vaccine in Catalonia, a Region with Low Vaccination Coverage

C. Muñoz-Almagro, L. Selva, P. Ciruela, 2016, The Pediatric infectious disease journal.

[Impact of 7-valent pneumococcal conjugate vaccination in a population with low to intermediate vaccination levels].

P. Ciruela, Á. Domínguez, E. Borràs, 2009, Enfermedades infecciosas y microbiologia clinica.

High prevalence of genetically-determined mannose binding lectin deficiency in young children with invasive pneumococcal disease.

C. Muñoz-Almagro, L. Selva, P. Ciruela, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2022, Emerging infectious diseases.

Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination

E. Sanders, M. Valenciano, A. van der Ende, 2018, Thorax.

Estimation of the invasive disease potential of Streptococcus pneumoniae in children by the use of direct capsular typing in clinical specimens

P. Brotons, C. Muñoz-Almagro, L. Selva, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project

P. De Wals, L. Hammitt, J. Scott, 2021, Microorganisms.

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.

B. Henriques-Normark, C. Muñoz-Almagro, J. Castilla, 2017, The Lancet. Respiratory medicine.

Integrated genomic surveillance enables tracing of person-to-person SARS-CoV-2 transmission chains during community transmission and reveals extensive onward transmission of travel-imported infections, Germany, June to July 2021

A. Dilthey, H. Jomaa, K. Pfeffer, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Rubella elimination programme strengthened through measles elimination programme in Catalonia.

P. Ciruela, N. Torner, A. Martínez, 2006, Vaccine.

The current screening programme for congenital transmission of Chagas disease in Catalonia, Spain.

A. Plasència, P. Ciruela, L. Basile, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Epidemiology of congenital Chagas disease 6 years after implementation of a public health surveillance system, Catalonia, 2010 to 2015

A. Martín-Nalda, P. Ciruela, J. Gascón, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, Spain.

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2020, Enfermedades infecciosas y microbiologia clinica.

The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact?

P. Godoy, A. Prats-Uribe, I. Barrabeig, 2021, BMC Public Health.

Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13

M. Benítez, C. Muñoz-Almagro, P. Ciruela, 2021, Microbiology spectrum.

Characteristics of patients with invasive pneumococcal disease requiring admission to intensive care units

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2020 .

Epidemiological, Clinical, and Microbiological Characteristics of Serotype-3 Streptoccocus pneumoniae Infection after a Partial Introduction of the 13-Valent Pneumococcal Conjugate Vaccine: A Prospective Observational Study

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2020, Journal of Pediatric Infectious Diseases.

Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era

C. Muñoz-Almagro, P. Ciruela, S. Uriona, 2020, Epidemiology and Infection.

Dissemination of NDM-producing Klebsiella pneumoniae and Escherichia coli high-risk clones in Catalan healthcare institutions.

Á. Soriano, J. Vila, A. Cuscó, 2020, The Journal of antimicrobial chemotherapy.

Pneumococcal serotypes in children and relationship with clinical presentation and antimicrobial susceptibility in the PCV13 era

P. Ciruela, A. Planes, S. Uriona, 2019 .

The Catalan Surveillance Network of SARS-CoV-2 in Sewage: design, implementation, and performance

L. Corominas, A. Bosch, S. Guix, 2022, Scientific Reports.

Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.

A. van der Ende, M. Knol, S. Ladhani, 2022, Vaccine.

[Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine].

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2021, Anales de pediatria.

Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, Spain

C. Muñoz-Almagro, P. Ciruela, J. García-García, 2021, Enfermedades infecciosas y microbiologia clinica (English ed.).

Epidemiology and antimicrobial resistance profile of Neisseria gonorrhoeae in Catalonia, Spain, 2016–2019

J. Ramírez, J. Niubó, M. Benítez, 2023, European Journal of Clinical Microbiology & Infectious Diseases.

Clonal Spread and Intra- and Inter-Species Plasmid Dissemination Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales During a Hospital Outbreak in Barcelona, Spain

Á. Soriano, J. Vila, A. Cuscó, 2021, Frontiers in Microbiology.

Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.

C. Muñoz-Almagro, I. Jordan, L. Selva, 2011, Vaccine.

The first wave of the COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes, as at 27 April 2020

P. Ciruela, A. Larrauri, M. Salom Castell, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.